Exhibits
2018 Exhibitors & Booth Assignments
EXHIBIT HOURS:
Sunday, June 24, 6:00 PM–7:30 PM—Welcome Reception and Poster Session 1 in Exhibit Hall
Monday, June 25, 5:30 PM–7:00 PM—Poster Session 2 in Exhibit Hall
Tuesday, June 26, 6:00 PM–7:30 PM—Poster Session 3 in Exhibit Hall
Exhibit hours are subject to change.
Download Exhibit Hall Floor Plan PDF
EXHIBITORS
As of March 24, 2018
 |
|
| Battelle | Tel: 410.306.8680 |
| 505 King Avenue | Website: www.battelle.org |
| Columbus, OH 43201 | |
| United States |
Battelle, the world's largest, independent R&D organization, conducts Developmental and Reproductive (DART) studies for a broad range of chemicals and pharmaceuticals. We provide studies used for required preclinical studies for US FDA approval of new drug and biologic therapies, product registration for agrichemicals, and evaluation al and reproductive effects of industrial chemicals and environmental toxins.
 |
|
| Charles River | Tel: 877.CRIVER.1 |
| 251 Ballardvale Street | Website: www.criver.com |
| Wilmington, MA 01887 | |
| United States |
With a mission to deliver custom, flexible solutions, Charles River provides clients with exactly what they need to improved and expedite the development of new therapies. From discovery, all the way through to clinical support, our scientific experts leverage an expansive safety assessment portfolio, a range of laboratory support services and global state-of-the-art facilities to produce the quality data you need to optimize your drug development program, every step of the way.
 |
|
| Citoxlab | Tel: 450.9732240 |
| 445 Boulevard Armand Frappier | Website: www.citoxlab.com |
| Laval, QC H7V4B3 | |
| Canada |
With nine facilities, Citoxlab Group offers a comprehensive range of preclinical services to meet the needs of pharmaceutical, biotechnology, medical device, chemical and agrochemical companies worldwide. Citoxlab carries out studies in general and reproductive toxicology, carcinogenicity, immunology, pharmacology, pharmacokinetics, and bioanalysis/biomarkers.
 |
|
| Experimur | Tel: 773.254.2700 |
4045 South Morgan Street |
Website: www.experimur.com |
Chicago, IL 60609 |
|
Experimur is a full-service toxicology testing and research laboratory with extensive experience in the conduct of developmental (Seg I, II, & III) and reproductive (single and multi-generation) toxicity assessments, including sperm morphology and vaginal cytology, as well as general toxicity (acute, subchronic, chronic, and carcinogenicity), neurotoxicity, and pharmacokinetic/ADME studies in species ranging from rodents to primates. With an experienced and well-trained team that has worked together for over 28 years and successfully completed thousands of GLP-compliant preclinical studies, we are committed to providing our customers with top quality and unmatched service. We invite you to visit our spectacular custom-built, AAALAC-accredited, USDA-registered, 54,000 square feet state-of-the art facility and vivarium, which includes extensive in-house support services for histology diagnostic pathology, clinical pathology, and analytical chemistry.
|
|
Exponent, Inc. |
Tel: 571.227.7220 |
1800 Diagonal Road, Suite 500 |
Website: www.exponent.com |
Alexandria, VA 22314 |
Exponent’s veteran toxicologists and epidemiologists are drawn from the chemical and pharmaceutical industries, academia, and government. They have international regulatory experience in designing and interpreting developmental and reproductive toxicity (DART) and developmental neurotoxicology studies; assessing potential endocrine disruption; performing quantitative risk assessments and cancer risk assessments related to children. Our experts are also ready to assist you in complying with the new FDA Pregnancy and Lactation Labeling Rule.
|
|
Resero Analytics |
Tel: 317.997.1651 |
PO Box 881461 |
Website: www.reseroanalytics.com |
Indianapolis, IN 46208 |
Resero Analytics has DART data for 600 FDA-approved New Molecular Entities, and software to analyze and display these data. Query our database using menu-driven search or upload your DART data files for automated conversion to SEND-CT and benchmarking to FDA-NMEs with human exposure multiples. Our company’s objective is to help companies and regulators improve the quality and speed of data interpretation, analysis, and reporting.